At a time when some PBMs are cracking down on mounting specialty drug costs through tools like excluded drugs lists, Catamaran Corp. is taking a more measured approach. The excluded drugs list the PBM plans to release next month will not include specialty drugs.

Instead, Catamaran aims to use more traditional tools to keep growth in check, while employing its medication therapy management program to optimize use of drugs it does pay for.